BIB ETF
ProShares Ultra Nasdaq Biotechnology
BIB ETF Overview
BIB ETF (ProShares Ultra Nasdaq Biotechnology) is managed by ProShares with $87.1M in net assets. BIB expense ratio is 0.95%, holding 261 positions across sectors including Health Care, Financials, Information Technology. Inception date: 2010-04-06.
BIB performance shows a YTD return of 44.58%. The 1-year return is 93.99% and the 5-year return is 2.64%. BIB dividend yield stands at 0.19%, paid annually.
BIB top holdings include Nasdaq Biotechnology Index Swap Citibank Na (37.6%), Nasdaq Biotechnology Index Swap Bank Of America Na (36.1%), Nasdaq Bio Index Swap Bnp Paribas (26.3%), Nasdaq Biotechnology Index Swap Goldman Sachs International (19.9%), Nasdaq Biotechnology Index Swap Societe Generale (18.9%). Go to all BIB holdings, BIB sectors, or BIB dividends.
BIB can be compared against other funds. Use BIB overlap to find shared positions, or BIB vs another fund for a side-by-side view. BIB alternatives are available via the screener, along with tax-loss harvesting opportunities.